Foreign academician Zhen Liu of Japan Academy of Engineering and his entourage went into HSAP for investigation and research.
On the morning of January 11, 2025, Liu Zhen, a foreign academician of the Engineering Academy of Japan (EAJ), a professor and doctoral supervisor of the Graduate School of Nagasaki University of Integrated Sciences, and his party, accompanied by the relevant leaders of the Development Zone, came to HSAP again for investigation and research.
In December 2023, Prof. Liu Zhen had made a special trip to HSAP to visit the company, praised HSAP's independent innovation ability, and experienced the HRA health risk assessment and EIS red blood cell aggregation test, and gave affirmation to the rapidity and accuracy of the test. Coming to HSAP again, Prof. Liu Zhen learned about the company's equipment promotion and application in the past two years, as well as the progress of the research and development of new technology and equipment.
December 2023, Prof. Zhen Liu came to experience HRA and EIS testing
Mr. Chen Zhonglin, Chairman of HSAP, highlighted the progress made by the company in 2024: participated in the drafting of 1 national standard; participated in the research of 3 national issues; obtained 9 national patents; carried out academic cooperation with 10 universities, including Peking University and Northeastern University; published 3 academic papers; obtained 4 software certificates; obtained 5 national medical device registration certificates; 6 technologies were selected for the "China Good Technology" project library; products were exported to 28 countries, including the United States, Britain, Germany, Russia, Brazil, Spain, Hungary, Australia, Singapore and so on. 6 technologies have been selected as "China's Good Technology" project library; the products have been exported to 28 countries, such as the United States, the United Kingdom, Germany, Russia, Brazil, Spain, Hungary, Australia, Singapore, and so on.
Prof. Liu Zhen appreciated HSAP's R&D concept and R&D capability. He said that he could provide assistance in talent introduction, technology exchange and in developing the Japanese market, and hoped that HSAP would launch more and better medical devices.